Skip Navigation

InnovAiT 2008 1(10):666-667; doi:10.1093/innovait/inn132
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Charlton, R. C
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the RCGP. All rights reserved. For permissions please e-mail: journals.permissions@oxfordjournals.org

News & Views

Dr Rodger C Charlton

General Practitioner and Associate Clinical Professor, Warwick Medical School and Honorary Editor, RCGP Publications

E-mail: rodger.charlton@warwick.ac.uk

The first 150 words of the full text of this article appear below.


    Care for patients with epilepsy—guidelines
 
The latest available epilepsy guidelines are from NICE in 2004 and a National Service Framework in 2005. A useful review appears in Clinical Medicine in August. All patients with suspected seizures should be referred quickly, preferably within 2 weeks. The diagnosis is primarily clinical based on a history and an eyewitness and needs to be differentiated from syncope, or for example drop attacks. Investigations are not used to make a diagnosis of epilepsy but rather confirm the diagnosis and establish a cause. Accurate classification is important to determine both the prognosis and appropriate medication, ideally with monotherapy. Withdrawal of medication should be discussed with patients who have been seizure free for at least 2 years and the Driver and Vehicle Licensing Agency (DVLA) strongly advises that patients should stop driving during the period of withdrawal until 6 months afterwards. Enzyme-inducing drugs may reduce the efficacy of the combined oral contraceptive . . . [Full Text of this Article]


    Management of transient ischaemic attack
 

    The most difficult consultation
 

    Cervical cancer and vaccination
 

    Ukraine and polyclinics
 

    Knowledge of risk factors in cancer
 

    NICE prostate cancer guidelines
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?